Medicine & Life Sciences
3-(4-(2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
5%
African Americans
5%
Alpelisib
7%
Antibodies
6%
Apoptosis
5%
Biomarkers
7%
Breast
18%
Breast Neoplasms
100%
Cancer Survivors
5%
Carcinogenesis
6%
Cell Line
8%
Cell Movement
7%
Cell Proliferation
5%
Cell Survival
5%
Child
7%
Clinical Trials
10%
Colonoscopy
6%
Colorectal Neoplasms
15%
Delivery of Health Care
5%
Disclosure
11%
Down-Regulation
5%
Drug Therapy
7%
Early Detection of Cancer
16%
Emotions
8%
Epithelial Cells
9%
ErbB Receptors
31%
Estrogen Receptor Modulators
15%
Estrogen Receptors
22%
Estrogens
13%
Fulvestrant
9%
Gefitinib
7%
Genes
5%
Growth
15%
Growth Factor Receptors
8%
Herniorrhaphy
5%
Heterografts
12%
Hispanic Americans
10%
Hormones
9%
human ERBB2 protein
15%
IGF Type 1 Receptor
5%
Income
5%
Inguinal Hernia
5%
Lapatinib
14%
Letrozole
14%
Ligands
13%
MCF-7 Cells
6%
Mitogen-Activated Protein Kinase Kinases
7%
Mutation
18%
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
8%
Neoplasm Metastasis
7%
Neoplasms
53%
Nude Mice
5%
NVP-BKM120
7%
Oncogenes
8%
Pharmaceutical Preparations
8%
Phosphatidylinositol 3-Kinase
25%
Phosphatidylinositol 3-Kinases
17%
Phosphorylation
9%
Phosphotransferases
15%
Population
5%
Progression-Free Survival
5%
Protein-Tyrosine Kinases
22%
Proteins
6%
Receptor Protein-Tyrosine Kinases
7%
Rhabdomyosarcoma
12%
ribociclib
7%
Survival
9%
Tamoxifen
9%
Therapeutics
17%
Transforming Growth Factor beta
5%
Transforming Growth Factors
34%
Trastuzumab
25%
Triple Negative Breast Neoplasms
13%